ResearchARVN

ARVN: FY25 Deep Dive

Ddrillr ResearchOriginal research

Published Sep 3, 20261 min read

Summary

Arvinas FY25 at $263M. NI $-81M; EPS $-1.28.

FY25 revenue $263M; OI $-115M; NI $-81M; EPS $-1.28.

Arvinas FY25 (Dec 31, 2025) at $263M revenue. OpInc $-115M; NI $-81M; EPS $-1.28. Biotech — Protein Degraders.